← All stocks

Skye Bioscience, Inc.

SKYE Net selling

CIK 0001516551 #5235 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$280.63K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$280.63K

18 of 18 sales

Net

−$280.63K

−$280.63K against sales at will

By person

6 insiders · 18 transactions

0.7×

Punit Dhillon holds only 0.7 times base salary in stock. $454.34K of shares against $610.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Punit Dhillon last reported holding, valued at $0.32, the price Common Stock was last bought or sold at on the open market here, on 20 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

5AM Partners VII, LLC entity

10% owner

—

$140.31K (9)

−$140.31K

7,850,155

22.16%

$2.51M

−7.2%

Schwab Andrew J.

Director

—

$140.31K (9)

−$140.31K

7,850,155

22.16%

$2.51M

−7.2%

DHILLON PUNIT

Chief Executive Officer

—

1,419,823

4.01%

$454.34K

+244.0%

Grayson Paul A.

Director

—

259,701

0.7332%

$83.10K

−25.0%

ARSENAULT KAITLYN

Chief Financial Officer

—

166,342

0.4696%

$53.23K

−20.7%

Diep Tuan Tu

Chief Operating Officer

—

82,259

0.2322%

$26.32K

−19.2%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 21

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 18

Transactions with no price 0

Shares from compensation/vesting 1,090,000

History held since 28 Mar 2017